Beryl Drugs informs about compliance certificate

Beryl Drugs Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524606 | NSE:

22 Oct 2022 Evaluate

With reference to various conditions stipulated under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other regulation required to be complied by the listed Companies, Beryl Drugs has informed that it enclosed the following documents relating to quarter ended on 30.09.2022: Regulation 40(9) - Certificate from Practicing Company Secretary; Reconciliation of Share Capital Audit Report (SEBI- Dp Reg. 55A).

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1847.00
Dr. Reddys Labs.	1212.30
Cipla	1368.65
Lupin	2121.05
Zydus Lifesciences	1170.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.